| Company Name: | Celera Corporation | | Ticker Symbol: | CRA | | | WWW Address: | www.celera.com |
| CEO: | Kathy P. Ordonez | | No. of Employees: | 490 |
| Common Issue Type: | CS | | Business Description: | Celera Corporation is a health care business focusing on the integration of genetic testing into routine clinical care through a combination of products and services incorporating proprietary discoveries.
|
| | | Industry Information: | DIVERSIFIED SERVICES - Research Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 8.04 |  0.0 | - | - | | 8.06 | 8.03 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 660.7 | 82.2 | 0.96 | -0.30 | 0.00 | 0.0 | 0.0 | 8.42 - 5.35 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 8.04 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 660.7 | mil |
| Latest Shares Outstanding | 82.2 | mil |
| Earnings pS (EPS) | -0.30 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 261,569 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 80.4 | mil |
| Float as % of Shares Outstanding | 97.8 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 58.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 19.20 | % |
| Gross Profit Margin | 70.7 | % |
| EBITDA Margin | -7.3 | % |
| Pre-Tax Profit Margin | -13.3 | % |
| Assets Turnover | 0.2 | % |
| Return on Assets (ROA) | -2.9 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -3.1 | % |
| Current Ratio | 12.3 | |
| Leverage Ratio (Assets/Equity) | 1.1 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 4.07 | $ |
| Cash pS | 0.68 | $ |
| Book-Value pS | 6.86 | $ |
| Tangible Book-Value pS | 4.37 | $ |
| Cash Flow pS | 0.02 | $ |
| Free Cash Flow pS | 0.07 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.17 | |
| Price/Tangible Book Ratio | 1.84 | |
| Price/Cash Flow | 378.0 | |
| Price/Free Cash Flow | 118.1 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -0.1 | 101 | 17,977 | 18,493 |
| 4 Weeks | 8.26 | 7.81 | 8.00 | 0.5 | 101 | 21,355 | 363,043 |
| 13 Weeks | 8.42 | 6.00 | 6.49 | 23.9 | 125 | 21,536 | 1,292,139 |
| 26 Weeks | 8.42 | 5.53 | 5.92 | 35.8 | 123 | 12,644 | 1,542,524 |
| 52 Weeks | 8.42 | 5.35 | 6.99 | 15.0 | 94 | 9,153 | 2,279,130 |
| YTD | 8.42 | 5.92 | - | 27.6 | 121 | 15,196 | 1,428,446 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 8.04 | 8.05 | 7.94 | 6.72 | 6.70 | 0.96 | 0.95 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 27.75 | 62.7 | -0.64 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 2.22 | NA | -67.86 |
| R&D | -20.72 | NA | -4.14 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 10.7 | 10.7 | -23.3 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.09 | 0.09 | 0.10 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 54.74 |
| Current Ratio | 12.0 |
| Quick Ratio (Acid Test) | 11.3 |
| Liquidity Ratio (Cash) | 10.71 |
| Receivables Turnover | 5.0 |
| Average Collection Period | 72 |
| Working Capital/Equity | 59.1 |
| Working Capital pS | 4.08 |
| Cash-Flow pS | -0.07 |
| Free Cash-Flow pS | -0.02 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 9.52 |
| Financial Leverage Ratio (Assets/Equity) | 1.1 |
| Debt Ratio | 7.3 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 2.5 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 1.47 |
| Tobin's Q Ratio | 1.08 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -24.12 |
| Enterprise Value (EV)/Free Cash Flow | -257.54 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 1.84 |
| Price/Book Ratio - LTM | 1.17 |
| Price/Cash Flow Ratio | 378.0 |
| Price/Free Cash Flow Ratio - LTM | 118.1 |
| Price/Sales Ratio | 5.02 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.37 |
| Tangible Book Value pS - LTM | 4.37 |
| Book Value pS - LTM | 6.86 |
| Capital Invested pS | 6.91 |
| Cash pS - LTM | 0.68 |
| Cash Flow pS - LTM | 0.02 |
| Free Cash Flow pS - LTM | 0.07 |
| Earnings pS (EPS) | -0.30 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -1.40 |
| Free Cash Flow Margin 5YEAR AVG | -49.45 |
| Net Profit Margin | -19.2 |
| Net Profit Margin - 5YEAR AVRG. | -34.1 |
| Equity Productivity | 0.23 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 0.23 |
| Return on Capital Invested (ROCI) | -4.3 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -6.2 |
| Assets Productivity | 0.20 |
| Return on Assets (ROA) | -4.0 |
| Return on Assets (ROA) - 5YEAR AVRG. | -5.8 |
| Gross Profit Margin | 70.7 |
| Gross Profit Margin - 5YEAR AVRG. | 73.7 |
| EBITDA Margin - LTM | -7.3 |
| EBIT Margin - LTM | -13.3 |
| Pre-Tax Profit Margin | -19.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -24.0 |
| Effective Tax Rate | -0.9 |
| Effective Tax Rate - 5YEAR AVRG. | -102.6 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 129 |
| Revenue per Employee | 261,569 |
| Net Income per Employee | -50,210 |
| Average Collection Period | 54 |
| Receivables Turnover | 5.0 |
| Day's Inventory Turnover Ratio | 75 |
| Inventory Turnover | 4.8 |
| Inventory/Sales | 7.0 |
| Accounts Payble/Sales | 7.82 |
| Assets/Revenue | 5.00 |
| Net Working Capital Turnover | 0.38 |
| Fixed Assets Turnover | 0.52 |
| Total Assets Turnover | 0.2 |
| Revenue per $ Cash | 3.67 |
| Revenue per $ Plant | 10.51 |
| Revenue per $ Common Equity | 0.23 |
| Revenue per $ Capital Invested | 0.23 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 63.1 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 63.8 |
| Research & Devlopment (R&D) as % of Revenue | 19.8 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 19.8 |
|
|  
|
| |
 |  |
